• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 2.16% Nasdaq Down 1.71%

    Arrowhead Research Corp. (ARWR)

    -NasdaqGS
    5.78 Down 0.15(2.53%) 10:52AM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:5.93
    Open:5.79
    Bid:5.84 x 500
    Ask:5.85 x 300
    1y Target Est:9.50
    Beta:2.32071
    Earnings Date:Nov 23 - Nov 27 (Est.)
    Day's Range:5.72 - 5.92
    52wk Range:4.35 - 17.42
    Volume:248,280
    Avg Vol (3m):1,054,380
    Market Cap:343.92M
    P/E (ttm):N/A
    EPS (ttm):-1.61
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ARWRDown 2.53%343.92M
    PENC 0.00%16.66M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):923.65
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Sep-15) :-1.58
    Quarterly EPS Est (Sep-15) :-0.39
    Mean Recommendation*:2.6
    PEG Ratio (5 yr expected):-0.49

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Arrowhead Research Corporation develops novel drugs to treat intractable diseases in the United States. The company’s principal product candidates comprise ARC-520, an RNAi-based therapeutic that is in Phase IIa clinical trial to treat chroni... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback